Press Releases

For more information about Orthomimetics please also see our Factsheets page.

TiGenix closes Orthomimetics acquisition

Tuesday, December 01 2009 Leuven (BELGIUM) – TiGenix announces the successful closing of the acquisition of Orthomimetics Limited, a privately held medical technology company based in Cambridge, the United Kingdom. More...

TiGenix to acquire Orthomimetics

Monday, 16 November, 2009 TiGenix strengthens its product portfolio and biomaterials platform through the acquisition of Orthomimetics, a privately held medical technology company based in Cambridge, the United Kingdom. This acquisition fits with TiGenix’ growth strategy of becoming a leading player in the promising and fast-growing field of regenerative medicine. More...

Orthomimetics reaches patient recruitment milestone in key European clinical study.

Monday, 14 September, 2009 Orthomimetics, the UK based regenerative medicine company has reported treatment of the tenth patient in a clinical study for Chondromimetic, a dual-layered implant for the repair of damaged cartilage and bone. More...

Orthomimetics expands Board of Directors

Tuesday, 30 June, 2009 Orthomimetics, the Cambridge-based developer of products for regenerative medicine, has appointed Patrick West, former Global Vice President of Sales and Marketing at Stryker Biotech, to its Board of Directors. More...

Orthomimetics selected as finalist for the MacRobert Award

Friday, 5 June, 2009 Orthomimetics, the UK based regenerative medicine company, has been chosen as one of four finalists from a record number of entries for the prestigious Royal Academy of Engineering MacRobert Award. More...

First patient treated with implant for regenerative repair of articular cartilage and bone.

Friday, 6 March, 2009 Orthomimetics, the UK based regenerative medicine company, has enrolled the first patient in its European pilot clinical trial of Chondromimetic, the company's flagship product for the repair of articular cartilage and bone. More...

Orthomimetics Secures CE Mark Approval for Chondromimetic.

Wednesday, 14 January, 2009 Orthomimetics Limited, the UK-based regenerative medicine company, has received CE Mark approval for Chondromimetic, its flagship product for the repair of articular cartilage and bone. More...

Dr Andrew Lynn receives European Award for University Spin-out Success.

Thursday, 4 December, 2008 Dr Andrew Lynn, Founder and CEO of Orthomimetics Ltd, has been selected from a host of entrants to receive the top European Award for University Entrepreneurs in Chemistry and Materials in the inaugural Academic Enterprise Awards 2008. The award is in recognition of his achievements as founder of a successful spin-out from a collaboration between the University of Cambridge and the Massachusetts Institute of Technology. More...

Orthomimetics receives £600K from TSB for development of Tissue Regeneration Product.

Wednesday, 22 October, 2008 Orthomimetics, the Cambridge based medical device company, continues to broaden its product portfolio with a third grant of Government funding. This £600,000 Technology Strategy Board (TSB) grant will support an R&D project for improving joint tissue regeneration. It is based on the use of a combination cell therapy technique with OM's tissue specific 3-D scaffolds. More...

Orthomimetics Appoints László Hangody and Anthony Miniaci to its Medical Advisory Board.

Wednesday, 10 September, 2008 Orthomimetics Limited has announced the appointment of Dr Anthony Miniaci MD of the Cleveland Clinic and Professor László Hangody of Uzsoki Hospital to its Medical Advisory Board. Professor Hangody and Dr Miniaci join Professor Neil Rushton of the University of Cambridge on the Orthomimetics Medical Advisory Board to provide the Cambridge, UK-based designer and manufacturer of regenerative medical implants with input into its clinical and product-development programmes. More...

Orthomimetics Scoops Cambridge News Business Excellence Award

Wednesday, April 09, 2008 Orthomimetics, the developer of novel regenerative medicine approaches for cartilage and ligament repair, joined other successful businesses at the Cambridge News Business Awards Ceremony held at King’s College, Cambridge, and overcame strong competition to win the ‘Rising Star’ category. More...

Orthomimetics Awarded £747k Grant to Develop Second Product

Wednesday, January 23, 2008A consortium led by Orthomimetics (OM) has been awarded £747k ($1.5m) from the UK Technology Strategy Board (TSB) for the commercial development of LigaMimetic, the second product based on OM’s technology platform. More...

Ministerial visit marks £3.25 million project to help sports injuries heal faster

Sunday, June 17, 2007Athletes could soon have access to new technology for helping repair cartilage with a medical device being developed by Cambridge-based OrthoMimetics Limited. More...

Orthomimetics (Cambridge, UK) Raises £5m Series A Investment

Tuesday, December 05, 2006Orthomimetics Limited, the first technology spin-out from the Cambridge-MIT Institute, has completed a Series A funding round totalling £5.0m ($9.6m) net of costs. More...

Exclusive license signed by CMI and Orthomimetics

Tuesday, May 30, 2006 A revolutionary technology to help reduce the need for joint replacement surgery has been developed by a team of surgeons, scientists and engineers from the University of Cambridge and MIT. More...

OM Featured in Captum Newsletter

Friday, March 31, 2006 Orthomimetics was formed in 2005 as the first spin-out venture from the Cambridge-MIT Institute to address the problem of limited lifetimes of joint replacements, a $30 billion industry. More...

Biotech entrepreneur, educate thyself!

Thursday, December 15, 2005 In recent years, a number of universities have created graduate degrees in biotech and business. Although it's still too early to measure their value, it appears that they are already inspiring debate and some startup activity. More...

Orthomimetics: Cambridge-MIT spin-out's technology aims to delay joint surgery

Thursday, November 24, 2005 OrthoMimetics, the first technology spin-out to emerge from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding. More...

East of England companies wow judges to win running the Gauntlet Investment

Friday, November 18, 2005 Three companies were successful in securing investment funding (subject to contract) from CREATE in the East of England Development Agency's running the gauntlet competition for entrepreneurs. More...

Cambridge-MIT company makes it to finals of prestigious entrepreneurship contest

Wednesday, November 16, 2005 The first technology company to emerge from the collaboration between the University of Cambridge and the Massachusetts Institute of Technology (MIT) has made it to the finals of a prestigious entrepreneurship contest. More...

Helping the body heal itself

Tuesday, November 15, 2005 The first technology company to emerge from the collaboration between the University of Cambridge and the Massachusetts Institute of Technology (MIT) has made it to the finals of a prestigious entrepreneurship contest. More...

East of England finalists to go head-to-head for running the Gauntlet Investment funding

Monday, October 31, 2005 Ten companies from across the East of England are through to the final of the East of England Development Agency (EEDA) running the gauntlet business competition – giving them the chance of securing a share of £1m in investment funding and £200,000 of in-kind business services. More...

Competition hots up as running the gauntlet short list is announced

Tuesday, September 13, 2005 Fifty entrepreneurs are in line for a share of £1 million of investment funding after being short listed in the UK's biggest business competition. More...